Table 2.
Source | Type | Inducer | Models | Function | References |
---|---|---|---|---|---|
Cladosiphon okamuranus Tokida | Fucoidan | H2O2 | Caco-2 cells | Fucoidan remarkably reduced H2O2-induced paracellular permeability. Up-regulation of endogenous expression of claudin-1, claudin-2, and occludin in Caco-2 cells. | [15] |
Acaudina molpadioides | Fucoidan | Cyclophosphamide (CPA) |
Mice | Fucoidan intervention alleviates inflammation, increases tight junction protein expression, and increases the abundance of Coprococcus, Rikenella, and Butyricicoccus. | [54] |
Laminaria japonica | Fucoidan | cefoperazone | Mice | Inhibiting the production of pro-inflammatory cytokines, restored the richness and diversity of intestinal microbiota, and improved the structural damage of intestinal mucosa. | [53] |
Cladosiphon okamuranus | Fucoidan | - | Zebrafish | Down-regulation of the relative expression of the pro-inflammatory gene IL-1β. | [71] |
Ascophyllum nodosum | Fucoidan | ciprofloxacin-metronidazole | Mice | Increased the abundance of Ruminococcaceae, and Akkermansia, and decreased the abundance of Proteus and Enterococcus; inhibited the overproduction of TNF-α, IL-1β, and IL-6, and promoted the expression of IL-10. | [28] |
Sargassum fusiforme | Sulfated polysaccharide | - | - | In vitro fermentation increased the abundance of Faecalibacterium, Phascolarctobacterium, Bifidobacterium, and Lactobacillus. | [72] |
Laminaria | Alginate | CPA | Mice | Up-regulation of tight junction protein expression reduced intestinal mucosal damage, decreased serum D-lactate and lipopolysaccharide concentrations, and downregulated toll-like receptor 4 (TLR4) and mitogen-activated protein kinase (MAPK) pathway expression to reduce intestinal inflammation. | [73] |
Fucus vesiculosus | Fucoidan | LPS | RAW 264.7 Cell | Inhibited the secretion of NO, PGE 2 and TNF-α, IL-1β and reduced the production of intracellular reactive oxygen species. | [74] |
Ascophyllum nodosum | Alginate | - | - | Promoted the growth of Bifidobacteria and Lactobacilli, increased levels of acetate and propionate. | [75] |
Laminaria japonica | Alginate | - | - | Increased the abundance of Bacteroides. | [76] |
Eisenia bicyclis | Laminaran | - | - | Inhibited ammonia, phenol, and indole production by human fecal microbiota and reduced indole levels in the cecum. | [77] |
Ecklonia radiata | Polysaccharides | - | - | Increase in total bacteria, Bifidobacterium, Lactobacillus and increase in total SCFA, acetic and propionic acids. |
[19] |
Ecklonia cava | Fucoidan | LPS | Zebrafish | Inhibiting ROS and NO production induced by LPS treatment to alleviate inflammation. | [20] |
Sargassum fusiforme | Fucoidan | Streptozotocin | Mice | Fucoidan significantly reduced fasting blood glucose, improved glucose tolerance, reduced oxidative stress in diabetic mice, and increased the abundance of beneficial intestinal microbes including Bacteroides, Faecalibacterium and Blautia. | [24] |
Sargassum fusiforme | Fucoidan | High-fat diet | Mice | Fucoidan improves HFD-induced insulin resistance by activating the Nrf2 pathway, remodeling the intestinal microbiota, and reducing intestinal inflammation. | [25] |
Laminaria japonica | Fucoidan | CPA | Mice | Fucoidan increased spleen and thymus indices, increased serum levels of IL-6, IL-1β, TNF-α, and IgG, and improved immunosuppression in mice. Increased the abundance of Lactobacillaceae and Alistipes, and decreased the abundance of Erysipelotrichia, Turicibacter, Romboutsia, Peptostreptococcaceae, and Faecalibaculum. | [78] |
Ascophyllum nodosum | Fucoidan | ciprofloxacin-metronidazole | Mice | Dietary fucoidan prevented colon shortening and alleviated colon tissue damage by increasing the abundance of potentially beneficial bacteria (e.g., Ruminococcaceae_UCG_014 and Akkermansia) and decreasing the abundance of harmful bacteria (e.g., Aspergillus and Enterococcus), fucoidan also inhibited the overproduction of TNF-α, IL-1β, and IL-6 and promoted the expression of IL-10. | [28] |
Fucus vesiculosus | Fucoidan | Sodium palmitate | HepG2 Cells Mice | Fucoidan significantly reduced the phosphorylation level of JNK and increased the phosphorylation of protein kinase B (pAkt). It improved hyperglycemia and serum insulin levels in mice with metabolic syndrome. | [31] |
Undaria pinnatifida | Fucoidan | High-fat diet | Mice | Fucoidan reduces weight gain, fat accumulation and intestinal permeability in mice with metabolic syndrome. Intestinal Firmicutes and Bacteroidetes in fucoidan-treated high-fat diet mice were restored to normal levels and promoted the production of SCFAS and enhanced the expression level of IL-10. | [32] |
Sargassum thunbergii | crude polysaccharide | - | - | Increased abundance of intestinal beneficial bacteria such as Bifidobacterium, Roseburia, Parasutterella, and Fusicatenibacter by in vitro fecal fermentation after 24 h of fermentation. | [79] |
Laminaria japonica | Fucoidan | - | Mice | Increased in the abundance of Ruminococcaceae and Lactobacillu and decreased in the serum levels of lipopolysaccharide-binding protein. |
[80] |